🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study aims to observe and evaluate the efficacy and safety of the peri...
Status
Terminated
Location
the First Affiliated Hospital, School of Medicine, Zhejiang University
Start Date
2020-12-26
Trial ID
NCT04653389
Treatments Being Tested
The purpose of this study is to investigate the efficacy and safety of long...
Status
Completed
Location
Kameda Medical Center
Start Date
2018-02-18
Trial ID
NCT03416374
Treatments Being Tested
The purpose of this trial is to examine the benefits of early combination o...
Status
Completed
Location
The Ohio State University Multiple Sclerosis Center
Start Date
2006-08
Trial ID
NCT00618527
Treatments Being Tested
The main purpose of this study is to assess the safety and tolerability of ...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2013-06
Trial ID
NCT01870297
Treatments Being Tested
To compare the safety of efficacy of abarelix versus goserelin plus bicalut...
Status
Completed
Location
Multiple Locations
Start Date
1999-01
Trial ID
NCT00841113
Treatments Being Tested
Most of patients with autoimmune encephalitis are left with permanent cogni...
Status
Completed
Location
The First Affiliated Hospital, Zhejiang University
Start Date
2017-04-07
Trial ID
NCT03530462
Treatments Being Tested
The goal of this interventional study is to evaluate the pharmacokinetics, ...
Status
Unknown
Location
ICBio Clinical Research Pvt. Ltd.
Start Date
2022-10-29
Trial ID
NCT05619770
Treatments Being Tested
The main goal of this trial is to evaluate the safety and tolerability of C...
Status
Recruiting
Location
Shanghai Mengchao Cancer Hospital
Start Date
2024-03-07
Trial ID
NCT06327997
Treatments Being Tested
The objective of the trial is to study whether daily treatment with liraglu...
Status
Completed
Location
University of Oulu and Oulu University Hospital, Dept of Children and Adolescents
Start Date
2016-03
Trial ID
NCT02898506
One of the possible options for the treatment of MS at present is a high-do...
Status
Recruiting
Location
First Pavlov State Medical University of St. Petersburg
Start Date
2020-10-01
Trial ID
NCT05832515
Treatments Being Tested